Why the study?
STEMI is a major cause of morbidity and mortality, but real-world data describing clinical characteristics, treatment patterns, and reperfusion outcomes in Peru were needed.
Does successful reperfusion reduce in-hospital adverse events in patients with STEMI?
Cohort (n=374)
Yes
Does successful reperfusion reduce in-hospital adverse events in patients with STEMI?
Answers are grounded in this paper and cite their sources.
In a Peruvian registry of STEMI patients, successful reperfusion was significantly associated with reduced in-hospital cardiovascular mortality and heart failure, though a large proportion of patients still faced delays or lacked access to reperfusion.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chacón-Díaz et al. (2021) conducted a cohort in ST-segment elevation myocardial infarction (n=374). Successful reperfusion vs. Unsuccessful or no reperfusion was evaluated on In-hospital mortality (RR 0.28, 95% CI 0.12-0.66, p=0.003).
Synapse has enriched 10 related papers. Consider them for comparative context: